Drug Channels

MAY 23, 2023

In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

AUGUST 6, 2024

In the video excerpt below, I walk through a brief history of 340B contract pharmacies. In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. Click here if you can’t see the video below.

Pharmacy 52

Pharmacy Hospitals Marketing Drugs 52

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. The largest 15 pharmacies accounted for more than 75% of total dispensing revenues from retail, mail, long-term care, and specialty pharmacies.

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Drug Channels

JUNE 17, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Three is still the magic number for pharmacy benefit managers (PBMs). Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

JULY 5, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drug Channels

NOVEMBER 15, 2023

In Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market , I documented how those networks now dominate stand-alone Medicare Part D prescription drug plans (PDPs) and have become a major presence in Medicare Advantage prescription drug (MA-PD) plans.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. The rise of discount card pricing within pharmacy benefit plans is a positive development. d/b/a Drug Channels Institute. Links below.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! to 1:30 p.m.

Pharmacy 97

Pharmacy Drugs Marketing 97

Drug Channels

MARCH 29, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. Pharmacies and Pharmacy Benefit Managers.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Marketing Drugs 97

Drug Channels

APRIL 4, 2024

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals International 52

Drug Channels

NOVEMBER 15, 2022

The rise of discount card pricing within pharmacy benefit plans is a positive development. Patients get access to market prices that can be lower than their PBM’s contracted rate. I’ll cover what’s next for PBMs and discount cards during my upcoming live video webinar, Drug Channels Outlook 2023 , on December 16, 2022, from 12:00 p.m.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JULY 20, 2022

In this issue: CVS disassociates itself from its chain pharmacy association Payers are paying attention to ICER Benefits of the biosimilar boom A fantastic takedown of health insurance deductibles Plus, I join the Advisory Board of Alto Pharmacy. d/b/a Drug Channels Institute. P.S. Join my nearly 30,000 (!) to 1:30 p.m.

Biosimilars 98

Biosimilars Pharmacy Drugs Marketing 98

Drug Channels

DECEMBER 12, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2023. During Friday’s webinar, I’ll be sharing my updated thoughts about the IRA’s impact on manufacturers, Part D plans, and patient behavior. d/b/a Drug Channels Institute.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Channels

JULY 25, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. The highly-consolidated PBM market notched another year of increased concentration. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 5, 2022

The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. Significant business relationships among the largest companies continue to shift market share.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

SEPTEMBER 9, 2020

In May, I recorded a brief video webinar for an on-demand business education session at Asembia's 2020 Specialty Pharmacy Summit Virtual Experience. Pharmacies and Pharmacy Benefit Managers. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Drugs 52

Drug Channels

NOVEMBER 15, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The Outlook 2022 marks our third annual outlook webinar.

Specialty Pharmacies 94

Specialty Pharmacies Biosimilars Pharmacy Drugs 94

Drug Channels

SEPTEMBER 23, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. I was struck by how quickly Cigna’s Express Scripts PBM business has increased revenues and prescriptions from its retail pharmacy network. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Marketing Drugs 97

Drug Channels

MAY 2, 2023

In my most recent video webinar , I explored how the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the prescription market. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing.

Pharmacy 97

Pharmacy Marketing Drugs 97

Drug Channels

JUNE 1, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest live video webinar: Drug Channels Update: 340B Controversies and Outlook. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Drugs Marketing 52

Drug Channels

JUNE 20, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program.

Marketing 98

Marketing Pharmacy Drugs 98

Drug Channels

NOVEMBER 29, 2022

In this issue: Mark Cuban schools Elon Musk on PBMs Market access lessons from Semglee Gen Z rejects the pharmacy career path A potent call for 340B transparency Plus, get ready to love the ‘90s again! Please join me for my upcoming live video webinar, Drug Channels Outlook 2023 , on December 16, 2022, from 12:00 p.m.

Pharmacy 97

Pharmacy Drugs Marketing Biosimilars 97

Drug Channels

SEPTEMBER 21, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. In Drug Channels Institute's list of the top 15 pharmacies of 2020 , we show that many of the largest U.S. d/b/a Drug Channels Institute.

Specialty Pharmacies 91

Specialty Pharmacies Pharmacy Marketing Drugs 91

Drug Channels

JUNE 24, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: 340B Controversies and Outlook. Next week, Drug Channels Institute will release our 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Specialty Pharmacies Marketing Drugs 52

Drug Channels

JUNE 22, 2023

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

DECEMBER 15, 2022

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channels Outlook 2023. Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market.

Marketing 98

Marketing Research Drugs Pharmacy 98

Drug Channels

JUNE 21, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022. d/b/a Drug Channels Institute.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

MARCH 9, 2021

Next week, Drug Channels Institute will release our 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 12th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmacy 52

Pharmacy Specialty Pharmacies Marketing Drugs 52

Drug Channels

JULY 9, 2020

In Drug Channels Institute's list of the top 15 pharmacies of 2019 , we show that many of the largest U.S. pharmacies are now central-fill mail and specialty pharmacies operated by PBMs and insurers. I see upside for specialty pharmacies in the aftermath of the pandemic. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Government Drugs 52

Drug Channels

DECEMBER 13, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. d/b/a Drug Channels Institute. Click here to see the original post and comments from August 2021.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

DECEMBER 14, 2020

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. Last week, news broke that Prime Therapeutics is expanding its relationship with Cigna’s Express Scripts to include mail and specialty pharmacy dispensing. d/b/a Drug Channels Institute. More to come.

Pharmacy 52

Pharmacy Specialty Pharmacies Marketing Drugs 52

Drug Channels

MAY 24, 2023

For more on PBMs, sign up for my new live video webinar, PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding , on June 23, 2023, from 12:00 p.m. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. to 1:30 p.m.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

DECEMBER 15, 2020

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. Its current market cap is an astounding $17.6 Below, I provide my overview of how our crazy drug channel system enables GoodRx’s good fortune. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

NOVEMBER 16, 2021

In Consolidation and Preferred Pharmacy Networks in 2022’s Medicare Part D Plans , I highlighted how those networks have hijacked the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JULY 29, 2022

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. d/b/a Drug Channels Institute. healthcare spending. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98